Documents & Downloads

Berupipam hemifumarate

Dopamine D1 Receptor Antagonist

Berupipam hemifumarate is a selective dopamine D1 receptor antagonist, primarily utilized for investigating its role in psychotic disorders. It serves as a substrate for UDP-glucuronosyltransferase (UGT), exhibiting high affinity for UGT enzymes while displaying variability in glucuronidation rates across different species and genders. This compound is valuable for research focused on dopamine-mediated pathways and their implications in neuropsychiatric conditions.

Out of Stock

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Specifications

Manufacturer	Adooq Bioscience
Actions	Antagonist
CAS Number	172940-14-6
Applications	Dopamine D1 Receptor Antagonist
Formula	C₂₃H₂₃BrClNO₆
Molecular Weight	524.79
SMILES	CN1C[C@H](C2=C3C(CCO3)=CC(Br)=C2)C4=CC(O)=C(Cl)C=C4CC1.OC(/C=C/C(O)=O)=O

Storage & Solubility

In Vitro Solubility

Reported Solubility

No reported solubility data are available for this product.

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.